Type III TGF-β receptor-independent signalling of TGFβ2 via TβRII-B, an alternatively spliced TGF-β type II receptor

EMBO Journal

Volumn 20, Issue 3, 2001, Pages 480-490

  Rotzer, Diana ^a   Roth, Martin ^a   Lutz, Marion ^a   Lindemann, Dirk ^a   Sebald, Walter ^a   Knaus, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Alternative splicing; Osteoblast TGF ; TGF receptor

Indexed keywords

RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

ALTERNATIVE RNA SPLICING; ARTICLE; CARTILAGE CELL; GENE ISOLATION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE I; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DISULFIDES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION; GLYCOSYLATION; HUMANS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

MAMMALIA;

EID: 0035254335     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.3.480     Document Type: Article

References (60)

1. Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system
2. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors
3. Requirement of type III TGF-β receptor for endocardial cell transformation in the heart
4. Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila
5. Transforming growth factor-β gene family members and bone
6. Isoform-specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C.
7. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Cloning, expression and alternative splicing of the receptor for anti-Mullerian hormone
10. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated
11. Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype
12. Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
13. Oligomeric structure of type I and type II transforming growth factor β receptors: Homo-dimers form in the ER and persist at the plasma membrane
14. Bone morphogenetic protein complexes on the surface of live cells: A new oligomerization mode for serine/threonine kinase receptors
15. The types II and III transforming growth factor-β receptors form homo-oligomers
16. A human transforming growth factor-β type II receptor that contains an insertion in the extracellular domain
17. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells
18. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin and bone morphogenetic protein-inducible enhancer
19. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction
20. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
21. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor
22. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma
23. Transforming growth factor-β1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease
24. Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction
25. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
26. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-β ligands
27. β-glycan presents ligand to the TGFβ signaling receptor
28. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling
29. TGF-β signal transduction
30. Controlling TGF-β signaling
31. The transforming growth factor β receptors types I, II and III form hetero-oligomeric complexes in the presence of ligand
32. GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor β and activin-A
33. TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4
34. A cDNA encoding the human transforming growth factor β receptor suppresses the growth defect of a yeast mutant
35. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors
36. Purification and characterization of transforming growth factor-β2.3 and -β1.2 hetero-dimers from bovine bone
37. Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells
38. Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells
39. Immunohistochemical localization of TGF β1, TGF β2 and TGF β3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development
40. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor
41. Scanning-deletion analysis of the extracellular domain of the TGF-β receptor II
42. Specificity, diversity and regulation in TGF-β superfamily signaling
43. Transforming growth factor-β3 is required for secondary palate fusion
44. Physiological actions and clinical applications of transforming growth factor-β (TGF-β)
45. Cooperative binding of transforming growth factor (TGF)-β2 to the types I and II TGF-β receptors
46. Systemic administration of recombinant transforming growth factor β2 (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats
47. Cloning and characterization of a human type II receptor for bone morphogenetic proteins
48. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity
49. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes
50. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor β2
51. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
52. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors
53. Expression cloning and characterization of the TGF-β type III receptor
54. Biosynthesis of the type I and type II TGF-β receptors. Implications for complex formation
55. Transforming growth factor-β induces formation of a dithiothreitol-resistant type I/type II receptor complex in live cells
56. TGF-β signals through a heteromeric protein kinase receptor complex
57. Mechanism of activation of the TGF-β receptor
58. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex
59. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
60. Receptor-associated Mad homologues synergize as effectors of the TGF-β response